Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate
Clinical trial NCT00265798 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00265798
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-14
- Primary completion
- 2010-02-11
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.